{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:27Z","timestamp":1790776827927,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gassur.2026.102542","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:51:10Z","timestamp":1785858670000},"page":"102542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma after pathologic complete response to neoadjuvant treatment: necessary or overtreatment?"],"prefix":"10.1016","volume":"30","author":[{"given":"Abolfazl","family":"Salari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuma N.","family":"Eruchalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-2121","authenticated-orcid":false,"given":"George","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gassur.2026.102542_bib1","series-title":"Cancer Statistics Center [Internet]","author":"American Cancer Society","year":"2025"},{"key":"10.1016\/j.gassur.2026.102542_bib2","series-title":"Pancreas [Internet]","author":"American Cancer Society","year":"2025"},{"issue":"2","key":"10.1016\/j.gassur.2026.102542_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zraf007","article-title":"Relationship between pancreatic cancer resection rate and survival at population level: systematic review","volume":"9","author":"Lockie","year":"2025","journal-title":"BJS Open"},{"issue":"10242","key":"10.1016\/j.gassur.2026.102542_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gassur.2026.102542_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","article-title":"Optimizing the outcomes of pancreatic cancer surgery","volume":"16","author":"Strobel","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2026.102542_bib6","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3390\/cancers14102417","article-title":"Current and future therapies for pancreatic ductal adenocarcinoma","volume":"14","author":"Sally","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.gassur.2026.102542_bib7","article-title":"Impact of tumor response after neoadjuvant treatment on overall survival among patients with pancreatic ductal adenocarcinoma: national cancer database analysis","volume":"16","author":"Sulciner","year":"2024","journal-title":"Cureus"},{"issue":"16","key":"10.1016\/j.gassur.2026.102542_bib8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102542_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102542_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1159\/000548583","article-title":"Updates and review of neoadjuvant therapy for resectable pancreatic cancer","volume":"104","author":"Cobb","year":"2025","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.gassur.2026.102542_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamaoncol.2022.5808","article-title":"Association of adjuvant chemotherapy in patients with resected pancreatic adenocarcinoma after multiagent neoadjuvant chemotherapy","volume":"9","author":"Sugawara","year":"2023","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102542_bib12","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/jamaoncol.2020.3537","article-title":"Evaluation of adjuvant chemotherapy in patients with resected pancreatic cancer after neoadjuvant FOLFIRINOX treatment","volume":"6","author":"van Roessel","year":"2020","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102542_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/SLA.0000000000003763","article-title":"Postoperative chemotherapy benefits patients who received preoperative therapy and pancreatectomy for pancreatic adenocarcinoma","volume":"271","author":"Perri","year":"2020","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gassur.2026.102542_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamasurg.2022.5696","article-title":"Evaluation of adjuvant chemotherapy survival outcomes among patients with surgically resected pancreatic carcinoma with node-negative disease after neoadjuvant therapy","volume":"158","author":"Hammad","year":"2023","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.gassur.2026.102542_bib15","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.hpb.2020.02.011","article-title":"The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter?","volume":"22","author":"Drake","year":"2020","journal-title":"HPB"},{"issue":"8","key":"10.1016\/j.gassur.2026.102542_bib16","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1245\/s10434-023-14809-1","article-title":"Long-term survival and recurrence patterns in locally advanced esophageal squamous cell carcinoma patients with pathologic complete response after neoadjuvant chemotherapy followed by surgery","volume":"31","author":"Wu","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102542_bib17","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1245\/s10434-023-13728-5","article-title":"Is pathologic complete response a good predictor for the long-term, clinical outcome in patients with gastric cancer after neoadjuvant chemotherapy? A retrospective, multi-institution study in China","volume":"30","author":"Lin","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102542_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102542_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.17625","article-title":"Pathological complete response in patients with resected pancreatic adenocarcinoma after preoperative chemotherapy","volume":"7","author":"Stoop","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.gassur.2026.102542_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/MPA.0000000000001590","article-title":"Evaluation of pathologic response on overall survival after neoadjuvant therapy in pancreatic ductal adenocarcinoma","volume":"49","author":"Sell","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.gassur.2026.102542_bib21","series-title":"National Cancer Database (NCDB) [Internet]","author":"American College of Surgeons","year":"2025"},{"issue":"1","key":"10.1016\/j.gassur.2026.102542_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/SLA.0000000000002672","article-title":"Is a pathological complete response following neoadjuvant chemoradiation associated with prolonged survival in patients with pancreatic cancer?","volume":"268","author":"He","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2026.102542_bib23","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Pancreatic Adenocarcinoma. Version 2.2025 [Internet]","author":"National Comprehensive Cancer Network","year":"2025"},{"issue":"11","key":"10.1016\/j.gassur.2026.102542_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2026.102542_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaoncol.2024.5917","article-title":"Adjuvant chemotherapy after resection of localized pancreatic adenocarcinoma following preoperative FOLFIRINOX","volume":"11","author":"Stoop","year":"2025","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102542_bib26","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1245\/s10434-025-17439-x","article-title":"Association between adjuvant therapy and survival in resected pancreatic ductal adenocarcinoma after different types and durations of neoadjuvant therapy","volume":"32","author":"Andel","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102542_bib27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3390\/cancers17111797","article-title":"Association of pathologic response and adjuvant chemotherapy with survival in resected pancreatic ductal adenocarcinoma following neoadjuvant therapy","volume":"17","author":"Yu","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.gassur.2026.102542_bib28","series-title":"Protocol for the Examination of Specimens From Patients With Carcinoma of the Pancreas [Internet]","author":"College of American Pathologists","year":"2025"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X26002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X26002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:30:12Z","timestamp":1790775012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X26002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1091255X26002234"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102542","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma after pathologic complete response to neoadjuvant treatment: necessary or overtreatment?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102542"}}